Fredrik Erlandsson

Company: Purespring Therapeutics

Job title: Chief Medical Officer

Seminars:

11:30 PM Advancing Precision Nephrology & Podocyte Targeted Gene Therapies 11:30 am

Sharing data on PS-001 for NPHS2 driven Focal and Segmental Glomerulosclerosis and PS-002 for complement driven glomerular diseases Exploring Phase 1 trial design considerations and including patient input Discussing next-steps in gene therapies for glomerular diseasesRead more

day: Conference Day 2

2:30 PM Overcoming Obstacles in Rare Kidney Disease Trials: From “One Patient, One Site” to a Collaborative Future 2:30 pm

Join this workshop to gain actionable insights to leverage innovative approaches in patient identification and clinical outcome tracking, contributing to more efficient, integrates and patient-centered healthcare ecosystem, leading to better experience and improved outcomes for individuals living with rare renal diseases. This workshop will gather experts to discuss: Exploring the economic and logistical burdens of…Read more

day: Pre-Conference Workshop Day